Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)-Reference-Cited by-同舟云学术

Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)

Published:2017 Issue:3. Vyp. 2 Volume:117 Page:55
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Stakhovskaya L. V.,Shamalov N. A.,Khasanova D. R.,Melnikova E. V.,Agafiina A. S.,Golikov K. V.,Bogdanov E. I.,Yakupova A. A.,Roshkovskaya L. V.,Lukinykh L. V.,Lokshtanova T. M.,Poverennova I. E.,Shepankevich L. A.

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Clinical Neurology

Reference14 articles.

1. Gusev EI, Skvortsova VI, Stakhovskaya LV. Epidemiology of stroke in Russia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2003;103:8:4-9. (In Russ.).

2. Gusev EI, Skvortsova VI. Neuroprotective therapy of ischemic stroke. I. Primary neuroprotection. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2002;102,5:3-7. (In Russ.).

3. Novikova LB, Sharafutdinova LR, Sharapova KM. The use of mexidol in acute period of ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013; 113:9-1:83-85. (In Russ.).

4. Shchulkin AV. Effect of mexidol on the development of the phenomenon of the neuronal excitotoxicity in vitro. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112:2:35-39. (In Russ.).

5. Stakhovskaya LV, Kotova SV. Insul't: rukovodstvo dlya vrachei. M.: OOO «Meditsinskoe informatsionnoe agentstvo». 2013;400. (In Russ.).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2024

2. The choice of a modern neuroprotective drug as a basic strategy in the treatment of chronic cerebrovascular diseases;Meditsinskiy sovet = Medical Council;2023-07-21

3. Antioxidant therapy in the complex treatment of patients with ischemic stroke in the acute and recovery period;Neurology, Neuropsychiatry, Psychosomatics;2023-04-30

4. Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis;Neurology, Neuropsychiatry, Psychosomatics;2023-04-29

5. The impact of therapy with Mexidol on neurological deficit and functional outcome in patients with ischemic stroke: a systematic review and meta-analysis;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023